Home
   
The Company
The History of SocraTec R&D
Our Goals and Visions
Our Services
Quality Management System
Cooperation Partners
Contact / Location
Clinical Investigations
Clinical Pharmacology Unit
Phase-I Studies
Phase-II/III Studies
Absorption-Site Studies
Proof-of-Concept Studies
Special Populations
Oncology
Magnetic Marker Monitoring
Procedure, Basic Principle
Testing Unit
Study Experience
Applications
Biopharmaceutics
Drug Substance
Dosage Form
BSC Classification
Product Improvement
Brain Trust, Expertise
Consulting Service
Expert Reports
Network of Experts
Development Concepts
Infocentre
Lectures/Presentations
Publications/Review Articles
Seminars/Conferences
Links
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  SocraTec R&D: Drug research and development with a concept

Success in clinical research and drug development requires interdisciplinary cooperation and a purposeful and goal-oriented approach. Sustainable progress can only be achieved by intelligent solutions. Which is where we offer our support as competent and reliable service provider.

Our activities are focussed on the biopharmaceutical characterization of both the active pharmaceutical ingredients and dosage forms as well as analyses of these in clinical trials, enrolling healthy subjects or selected patient populations. Defining the right concept and conducting research - for both proof-of-concept as well as pivotal studies - demand the experience that we have acquired from a long-standing track record in clinical research and drug development.

It is the objective of every sponsor to complete a project with the same efficiency and success whether it is carried out within the company or outsourced to a CRO. Scientific expertise and a professional, customer-orientated approach are key attributes for achieving these goals. Handling such challenges is our daily business. Which is why we see ourselves as an integral member of your project team.

 
 
  © 2003-2013 SocraTec R&D GmbH deutsche Version Imprint